Yanqing Wu

This paper develops and validates a novel murine model of in-stent neoatherosclerosis that replicates human disease characteristics.

This study shows that IL-35 pretreatment reduces LPS-induced heart injury by decreasing inflammation, apoptosis, and fibrosis through inhibiting NF-κBp65 and TGF-β1/Smad2/3 pathways.

This paper investigates how Hcy-induced atrial fibrosis is mediated by TRPC3 and SIRT1 interactions, showing increased fibrosis and TRPC3 expression in high-Hcy conditions.